Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
Clinical trial NCT02974647 · RECRUITING
Trial details
- NCT number
- NCT02974647
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2027-11-01
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.